Marion Burdin

Marion Burdin PhD is a strategic leader specializing in Rare Disease and Cancer Genomic Testing at Illumina since January 2015, where the role encompasses embedding innovative tests into NHS patient pathways and driving commercial strategies for Genomics England. Prior experience includes serving as an Executive Clinical Sales Specialist in Reproductive and Genetic Health, focusing on various aspects of maternal and fetal health, and a previous position as Account Manager for Molecular Diagnostics at PerkinElmer. Additional roles include Field Application Specialist for Roche NimbleGen Inc. and a Postdoctoral position at the University of Aberdeen. Marion Burdin holds a PhD in Molecular Biology from the University of Aberdeen and an MSc in Biotechnology Engineering from L'Institut Agro Montpellier.